Stuttgart - Delayed Quote EUR
Intellia Therapeutics Inc (38I.SG)
7.77
-0.24
(-2.97%)
As of 9:01:33 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-348,880
-348,880
-394,086
-333,287
-225,030
Investing Cash Flow
125,567
125,567
-31,347
160,309
-550,778
Financing Cash Flow
185,747
185,747
130,323
582,955
736,688
End Cash Position
202,787
202,787
240,353
535,463
125,486
Capital Expenditure
-5,778
-5,778
-13,985
-58,390
-12,756
Issuance of Capital Stock
176,899
176,899
119,795
565,789
693,570
Free Cash Flow
-354,658
-354,658
-408,071
-391,677
-237,786
12/31/2021 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VLA.VI Valneva SE
2.9220
-0.34%
HTD.MU Corcept Therapeutics Inc
63.62
0.00%
BT3.BE Lineage Cell Therapeutics Inc
0.4180
-3.24%
25I.SG ImmuPharma PLC
0.0285
-12.31%
328.SG MeiraGTx Holdings PLC
6.30
-2.33%
CLDWW Calidi Biotherapeutics, Inc.
0.0055
-15.38%
HQ1.MU Oruka Therapeutics Inc. R
9.20
+1.10%
8QQ.HM AbCellera Biologics Inc
2.0870
-4.49%
2I3.F Champions Oncology, Inc.
5.0000
-2.91%
PI3.DU Gubra AS
54.45
+0.83%